Search
for
Sort by
Research 241–270 of 1000+
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Early postnatal inhibition of neurosteroid synthesis changes the later-life adverse outcome of neonatal asphyxia in rats
- Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- The Lived Experience of Women with Alopecia: A Qualitative Study Investigating the Psychological, Social and Emotional Impact of Alopecia in a Sample of Greek Women
- Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland
- Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis
- Localized Epidermolysis Bullosa Simplex (Weber-Cockayne type)
- Avaliação da qualidade de vida, perda de peso e comorbidades de pacientes submetidos à cirurgia bariátrica
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Plant‐Derived Monomers for Grey Hair Reversal Through Upregulation of Melanogenesis and Tyrosinase Activity
- Advances in hair growth
- A New Office Based Protocol to Reverse AGA Miniaturization at Early and Advanced Stages
- Female pattern hair loss: therapeutic update
- Showing progress. Defining self-tracking as an aesthetic audio-visual genre
- The use of hair cortisol for the assessment of stress in animals
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Artificial intelligence: revolutionizing robotic surgery: review
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- The role of platelet-rich plasma in biomedicine: A comprehensive overview
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Structural injustice and the Requirements of Beauty
- International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds